OpenAlex
PricingAboutJobs
Log inGet started
Work

Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trial

HTML

Year: 2011
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Lancet Neurology
DOI: 10.1016/s1474-4422(11)70233-2
Authors: Justo Garcia de Yebenes, Bernhard Landwehrmeyer, Ferdinando Squitieri, Ralf Reilmann, Anne Rosser, Roger A Barker, Carsten Saft, Markus K Magnet, Alastair Sword, Åsa Rembratt, Joakim Tedroff
Institutions: Biomedical Research Networking Center on Neurodegenerative Diseases, Hospital Universitario Ramón y Cajal, Universität Ulm, Istituto Neurologico Mediterraneo, University of Münster, Cardiff University, University of Cambridge, St. Josef-Hospital, Ruhr University Bochum, University of Graz, NeuroSearch (Denmark)
Language: English

Topic: Genetic Neurodegenerative Diseases
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Keywords: Huntington's disease, pridopidine, motor function, chorea, Unified Huntington's Disease Rating Scale, drug efficacy, drug safety and tolerability, dose comparison, neurodegenerative disease treatment, Bonferroni correction, sensitivity analysis
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2167353335
FWCI: 4.778
Cites: 31
Cited by: 181
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms